Barinthus Biotherapeutics (BRNS) Other Working Capital Changes (2020 - 2026)
Barinthus Biotherapeutics (BRNS) has disclosed Other Working Capital Changes for 7 consecutive years, with -$1.0 million as the latest value for Q1 2026.
- For Q1 2026, Other Working Capital Changes fell 277.62% year-over-year to -$1.0 million; the TTM value through Mar 2026 reached -$2.5 million, down 1194.76%, while the annual FY2025 figure was -$1.7 million, 4.75% up from the prior year.
- Other Working Capital Changes hit -$1.0 million in Q1 2026 for Barinthus Biotherapeutics, down from -$227000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $2.7 million in Q2 2024 and bottomed at -$2.1 million in Q3 2024.
- Average Other Working Capital Changes over 5 years is -$251764.7, with a median of -$227000.0 recorded in 2025.
- On a YoY basis, Other Working Capital Changes climbed as much as 18193.33% in 2024 and fell as far as 1424.39% in 2024.
- Barinthus Biotherapeutics' Other Working Capital Changes stood at $430000.0 in 2022, then crashed by 146.74% to -$201000.0 in 2023, then plummeted by 140.3% to -$483000.0 in 2024, then skyrocketed by 53.0% to -$227000.0 in 2025, then tumbled by 360.79% to -$1.0 million in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods came in at -$1.0 million, -$227000.0, and -$504000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.